Skip to main content

Antibacterial activity of epigallocatechin gallate againstHelicobacter pylori: Synergistic effect with plaunotol

Abstract

The antibacterial activity of epigallocatechin gallate (EGCg), a main component of Japanese tea extract, was evaluated against 71 clinical isolates ofHelicobacter pylori recovered from patients with gastric ulcer disease at our hospital. The minimal inhibitory concentration (MIC) was distributed between 8 and 128 μg/mL, and the MIC90 was 64 μg/mL. The combination efficacy of EGCg with an anti-ulcer drug, plaunotol, was evaluated for antibacterial activity againstH. pylori. With addition of 6 μg/mL of plaunotol, the MIC for EGCg decreased significantly in all strains tested. tested. These results suggested that the combination of EGCg and plaunotol could be a useful regimen in the treatment of gastric ulcer.

This is a preview of subscription content, access via your institution.

References

  1. NIH Consensus conference:Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65–69.

    Article  Google Scholar 

  2. Kodama R, Fujioka T, Fujiyama K, Kawasaki H, Kubota T, Nasu M. Combination therapy with clarithromycin and sofalcone for eradication ofHelicobacter pylori. Eur J Gastroenterol Hematol 1994;6(suppl 1):S125-S128.

    Google Scholar 

  3. Sunairi M, Watanabe K, Suzuki T, Tanaka N, Kuwayama H, Nakajima M. Effect of anti-ulcer agents on antibiotic activity againstHelicobacter pylori. Eur J Gastroenterol Hematol 1994;6(suppl 1):S121-S124.

    Google Scholar 

  4. Kono K, Tatara I, Takeda S, Arakawa K, Hara Y. Antibacterial activity of epigallocatechin gallate against methicillin-resistantStaphylococcus aureus. J Jpn Assoc Infect Dis 1994;68:1518–1522.

    CAS  Google Scholar 

  5. Kobayashi S, Ishibashi C, Morita A, Masuda H, Ogiso A. Anti-ulcer activities of (E, Z, E)-7-hydroxymethyl-3, 11, 15-trimethyl-2, 6, 10, 14-hexadecatetraen-1-ol (CS-686), a new acyclic diterpene alcohol from a Thai medicinal plant, on experimental acute gastric and duodenal ulcers. Pharmacometrics 1982;24:599–607.

    CAS  Google Scholar 

  6. Koga T, Kawada H, Utsumi Y, Doman H, Ishii C, Yasuda H. In-vitro and in-vivo antibacterial activity of plaunotol, a cytoprotective antiulcer agent, againstHelicobacter pylori. J Antimicrob Chemother. 1996;37:919–929.

    PubMed  CAS  Google Scholar 

  7. Hirscal AM, Hirschl MM, Rotter ML. Comparison of three methods for the determination of the sensitivity ofHelicobacter pylori to metronidazole. J Antimicrob Chemother 1993;32:45–49.

    Google Scholar 

  8. Toda T, Okubo S, Hara Y, Shimamura T. Antibacterial and bactericidal activities of tea extracts and catechins against methicillin-resistantStaphylococcus aureus. Jpn J Bacteriol 1991;46:839–845.

    CAS  Google Scholar 

  9. Ikigai H, Nakane T, Hara Y, Simamura T. Bacterial catechins damage the lipid bilayer. Biochim Biophys Acta 1993;1147:132–136.

    PubMed  CAS  Article  Google Scholar 

  10. International Agency for Research on Cancer, World Health Organization Schistsomes, liver flukes andHelicobacter pylori. IARC Monogr Eval Carcinig Risk Hum 1994;61:218–220.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Kono, K., Tatara, I., Takeda, S. et al. Antibacterial activity of epigallocatechin gallate againstHelicobacter pylori: Synergistic effect with plaunotol. J Infect Chemother 3, 170–172 (1997). https://doi.org/10.1007/BF02491509

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02491509

Key words

  • Helicobacter pylori
  • epigallocatechin gallate
  • plaunotol